Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
about
EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.Cellular Cholesterol Homeostasis in Alzheimer's Disease.Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock.Allosteric pathways in nuclear receptors - Potential targets for drug design.MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.
P2860
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
@en
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
@nl
type
label
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
@en
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
@nl
prefLabel
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
@en
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
@nl
P2860
P356
P1476
Therapeutic potential of nuclear receptor agonists in Alzheimer's disease.
@en
P2093
Gary E Landreth
Miguel Moutinho
P2860
P356
10.1194/JLR.R075556
P577
2017-03-06T00:00:00Z